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ABSTRACT

The AlterG Anti-Gravity Treadmill allows individuals to walk at reduced body
weight by using lower body positive pressure (LBPP). PURPOSE: The purpose of this
study was to discern if the AlterG Anti-Gravity Treadmill was an effective tool to use in a
weight loss walking program with obese individuals when compared to walking on a
traditional treadmill. METHODS: Fifteen male (n = 3) and female (n = 12) obese
participants, aged 18-55 years old with an average body mass index [BMI] ≥ 30 kg/m2),
were randomly assigned to the AlterG treadmill (AlterG; n = 6) and traditional treadmill
(TT; n = 9). Participants followed an 18-week (three 6-week phases) weight loss walking
protocol and exercised 3 days a week. Each 6-week phase increased in intensity and
duration, and by Phase 3 participants were walking at an intensity of 60-85% HRmax for
60 minutes. The participant’s weight, BMI, and body fat percentage (BFP) were recorded
during the program. RESULTS: There was no significant overall weight loss difference
determined between the two groups. The AlterG and the TT group lost an average of 2.33
kg and 2.14 kg, respectively. Similarly, no significant overall differences in BMI and
BFP were found between the two groups. Significant differences were found among the
three phases of the weight loss intervention for weight loss (p = 0.024), BMI reduction (p
= 0.021), and BFP reduction (p < 0.0005). Each group exhibited significant decreases in
weight, BMI, and BFP by the conclusion of the study. CONCLUSION: This study
demonstrated that the walking protocol used with the AlterG Anti-Gravity Treadmill was
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effective in producing significant weight loss, decreased BMI, and reduced percent body
fat in obese individuals.
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CHAPTER ONE: INTRODUCTION

Obesity
Obesity, defined as a body mass index (BMI, calculated as weight in kilograms
divided by height in meters squared) of 30 kg/m2 or greater, is a growing trend, especially
in the United States. Obesity is the second leading cause of death behind tobacco usage
and cigarette smoking.1-7 It is a medical problem that can lead to numerous complications
such as diabetes, high blood pressure, high cholesterol, and increased risk of
cardiovascular disease across all ethnic and age groups.4,8 Obesity rates, as of 2009-2010,
were 35.5% and 35.8% for women and men, respectively, and the prevalence of obesity
is still high and increasing in certain ethnic groups, specifically non-Hispanic Black
women and Mexican American women.6 National studies have indicated that within 15
years, 80% of all American adults will be overweight or obese if weight loss measures
such as dietary intake and exercise are not utilized.9
Physical inactivity has been found to be the leading cause of cardiovascular and
metabolic conditions, such as obesity, diabetes, metabolic syndrome, hypertension, and
cardiovascular disease.9 Approximately 17% of adults are inactive and 41% of adults are
not getting a sufficient amount of exercise.9 An insufficient amount of physical activity or
exercise is considered less than 2.5 hours per week of moderate activity with the
recommended amount of exercise being 3 to 3.5 hours per week of moderate activity.9
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There is substantial evidence to suggest that increasing physical activity would
reduce the amount of cardiovascular and metabolic disorders.9 More specifically, an
inverse relationship has been demonstrated between exercise and premature mortality,
cardiovascular disease, hypertension, stroke, osteoporosis, diabetes, metabolic syndrome,
obesity, various types of cancers, such as colon and breast cancer, depression, falls, and
functional and cognitive health.1 Overall, it is critical for obese individuals to engage in
regular physical activities and exercise to reduce the potential for developing various
health-related illnesses and complications of obesity.

Musculoskeletal Pain and Obesity
Increasing physical activity levels with obese individuals is often difficult. One of
the challenges faced by this population is the additional weight that is placed on the hips,
knees, and ankles when performing walking or jumping activities. One of the
musculoskeletal complications of obesity is osteoarthritis, especially in the lower
extremities.10 In addition, the lack of lower extremity strength often observed in obese
individuals may amplify the potential to develop osteoarthritis, especially in the knee.10
Obesity can also cause several orthopedic disorders and can biomechanically change gait
patterns due to excessive weight-bearing forces.10 Impaired gait patterns frequently
develop to compensate for a lack of leg strength, which further compounds the pain obese
individuals may experience while walking or exercising.10 Fortunately, there are a variety
of interventions and treatment options available to aid in weight reduction and reduce the
prevalence of osteoarthritis, especially found in the knee.10
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Weight Loss Options
One treatment option for obese individuals is to undergo bariatric surgery, such as
gastric bypass surgery or gastric band surgery. These types of surgeries limit the amount
of food that can be consumed or change how food is digested.11 Whatever the type of
surgery, most people lose weight quickly when choosing this option. Substantial weight
loss from bariatric surgery has also been found to reduce musculoskeletal pain and
improve gait mechanics.11 While initial weight loss is certain, there are potential
complications associated with bariatric surgery such as bleeding, infection, blood clots,
poor food absorption, and hernias.11 In addition, bariatric surgery is expensive, ranging
from $20,000 to $30,000.11
Successful weight loss for obese individuals has been shown to occur through an
increase in exercise, an altered diet, and the use of weight loss medications.12
Unfortunately, diets can be hard to adhere to and maintain long-term, most weight loss
medications can produce negative or unwanted side effects, and medications are not
always cost efficient to continue over a period of time.12 Exercise has shown to be the
safest and most successful in producing desired weight loss.12 Regular exercise can
reduce the negative effects of obesity by decreasing stress, decreasing weight, and
reducing the risks for diabetes, heart disease, hypertension, and all-cause mortality
rates.1,2,13 Even when no weight loss is seen, regular exercise has been shown to increase
cardiovascular fitness levels, decrease stress, and reduce the risks for heart disease.
Weight loss of 5 – 10% body weight has been shown to produce more substantial health
benefits such as reducing the risk for chronic diseases including diabetes, heart disease,
many forms of cancer, and numerous musculoskeletal problems.1
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Low impact exercises have been used successfully with obese individuals.
Swimming is a non-weight bearing activity and has been shown to be an effective form
of exercise and weight loss.14 In addition, because walking or swimming in water
decreases impact on the lower extremities, joint pain can be reduced.15 However, because
of the lack of weight bearing while exercising in water, swimming has been shown to
produce no statistically significant increases in peak bone mass or bone structures.14
Conversely, weight-bearing activities on dry land have been shown to increase and
maintain peak bone mass as well as optimize bone structure.14 Moreover, while
swimming may be a beneficial exercise option for those who are obese, pool availability
and the psychological effects of wearing a bathing suit in front of others often make
swimming a questionable choice.14
In order to incorporate more weight-bearing activities for obese individuals,
modified impact exercise equipment have been designed. Various types of treadmills
have been developed to help support the weight of obese individuals while walking.
Harness supported treadmill walking was first used for patients as way of decreasing
loads in order to heal tissues, conserve energy, and reduce pain.15 Harness supported
treadmills allowed individuals to rehabilitate injuries within their functional capacity at
lower energy cost, yet still produced significant cardiovascular conditioning.15 More
recently, the National Aeronautics and Space Administration (NASA) developed a
treadmill that is located on board the International Space Station and is designed to allow
astronauts to run without vibrating delicate microgravity science experiments in adjacent
labs.16 Differential Air Pressure (DAP), created by NASA’s treadmill, is used to “weight”
the individual harnessed into the treadmill.16 This creates lower body negative pressure
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(LBNP) inside the chamber to pull fluids into the lower extremity (simulate gravity)
during the microgravity of spaceflight.16,17
Based on the advances made by NASA using LBNP, the AlterG Company
reversed the pressure (lower body positive pressure, LBPP), 17 to reduce weight in normal
gravity situations and created the AlterG Anti-Gravity Treadmill. With LBPP exercise,
the normal (lifting) force is equal to the pressure differences inside and outside the
chamber multiplied by the cross-sectional area of the waist seal and reduces the ground
reaction forces (GRFs) proportional to the amount of unweighting selected.16,17 This has
been approved as a clinical rehabilitation treadmill that allows an individual to exercise
while effectively unweighting themselves down to 20% of their actual body weight.17
The benefit of this unweighting capability is to reduce the stress and the impact forces on
the lower extremities and preserve or regain proper gait mechanics as well as proper
muscle firing and recruitment patterns in clinical and rehabilitation settings.17 Based on
the function of the AlterG Anti-Gravity Treadmill, it could be used as a weight-reduction
device to lessen the incidence of musculoskeletal pain in the lower extremities while
walking.

Need for Study
Although there are many treatment and exercise options available for obese
individuals to consider when beginning a weight reduction program, the AlterG AntiGravity Treadmill appears to be a beneficial alternative. The AlterG Anti-Gravity
Treadmill allows obese individuals to walk at lower percentages of their body weight
with the assistance of LBPP. The special feature of LBPP helps reduce the actual weight
placed on lower extremities and decreases the incidence of musculoskeletal pain that is
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typically seen in obese individuals when involved in weight-bearing exercises.10,11,17 In
addition, walking on the AlterG treadmill is a weight-bearing activity, which will
maintain bone mineral density. Finally, the ability to walk and exercise without the added
stress to soft tissue and joints could result in prolonged exercise sessions and extended
opportunities to reduce body weight in the fight against obesity. However, there is
insufficient evidence to support the effective use of the AlterG treadmill as a weight loss
tool with obese individuals. This pilot study will test weight-loss outcomes of a walking
program on the AlterG treadmill for obese individuals.

Purpose of Study
Therefore, the purpose of this study is to discern if the AlterG Anti-Gravity
Treadmill is an effective tool to use in a weight loss walking program when compared to
walking on a traditional treadmill.

Research Hypothesis
It was hypothesized that (1) regular use of the AlterG Anti-Gravity Treadmill
would result in statistically significant exercise-induced weight loss in obese individuals,
(2) the traditional treadmill group (TT) would lose more weight than the AlterG AntiGravity Treadmill (AlterG) group at the conclusion of the intervention, (3) the AlterG
group would have lower Numeric Pain Scores (NPS) while walking than those walking
on a traditional treadmill, and (4) the AlterG group would have higher compliance rates
during the intervention than the TT group.
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Significance of Study
The results of this study will be significant as the data will provide preliminary
evidence for using the AlterG Anti-Gravity Treadmill with obese individuals in a weight
loss program. The benefits to weight loss are well-documented and may include
decreased risk of heart disease and diabetes, increased capacity for activities of daily
living, decreased risk of musculoskeletal diseases, and enhanced self-image and general
appearance.1

Study Limitations
This research involved collecting data based on a weight-loss walking program in
a laboratory setting. While participants were asked to maintain their normal, daily
schedule and eating patterns during this study, additional physical activity or diet changes
initiated by the participants could affect the results. Every attempt was made to help
participants maintain consistent involvement in the study; however, unforeseen
circumstances may prevent some individuals from completing the study. Due to the
availability of one AlterG Anti-Gravity Treadmill, one traditional treadmill, and a sole
exercise technician, the number of participants in this study was limited, which may
reduce the statistical power of the results. Finally, because obese individuals from this
study were recruited from the Boise, Idaho area, the results of this study may not be
generalized to other obese individuals living in other communities.

Operational Definitions
•

Exercise: defined as planned skeletal muscle movement that results in caloric
expenditure 1
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•

Obesity: defined as a body mass index (BMI) of 30 kg/m2 or greater, which is
calculated as weight in kilograms divided by height in meters squared 6

•

Pain level: defined as the level of physical suffering of discomfort caused by
illness or injury as measured by the numeric pain scale (NPS) 18

•

Rate of perceived exertion (RPE): defined as the level of physical work being
performed as measured by the modified Borg scale 19
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CHAPTER TWO: LITERATURE REVIEW

The scope of the literature review will include the physiological and
musculoskeletal benefits of exercise, effects of exercise on weight loss, as well as the
benefits and significance of anti-gravity exercise. Studies were included in the literature
review if they discussed either weight loss programs or antigravity exercise for weight
loss or rehabilitative purposes.

Physiological and Musculoskeletal Benefits
Regular exercise has many physiological benefits, especially when used to
combat obesity. Engagement in regular exercise helps to prevent or manage high blood
pressure as well as manage cholesterol levels.1,20,21 Regular exercise can raise high
density lipoprotein (HDL) cholesterol, which is known as the “good cholesterol,” and
regular exercise can decrease low density lipoprotein (LDL) cholesterol, which is known
as the “bad cholesterol.”1,20,21 Maintaining appropriate cholesterol levels helps to manage
plague build-up, which explains why regular exercise can reduce risks for chronic
diseases such as cardiovascular disease, diabetes, and certain cancers.1,20,21 The American
Heart Association (AHA) states that “aerobic exercise capacity is one of the single best
predictors of risk for future adverse events in apparently healthy individuals, those at
increased risk for CVD, and virtually all patient populations independent of other
traditional risk factors.”20(p.883)
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Regular exercise can also reduce body weight through an increase in caloric
expenditure. For example, walking a mile burns close to 100 calories.1 A reduction in
weight has been shown to reduce the risks for diabetes, heart disease, and all-cause
mortality rates due to less adipose tissue.1-3 Even without associated weight loss, exercise
has been shown to increase cardiovascular fitness levels, decrease stress, and reduce the
risks for heart disease.1-3 However, a weight loss of 5 – 10% body weight, in conjunction
with exercise, has been shown to produce more substantial health benefits such as
reducing the risk for chronic diseases including diabetes, heart disease, many forms of
cancer, and numerous musculoskeletal problems.1-3
Regular exercise also has many musculoskeletal benefits. Bone density responds
to regular exercise by increasing peak bone mass.21 Maximum bone density is important
in order to decrease the risks of osteoporosis, and is especially important in women who
are more susceptible to develop osteoporosis.21 Bone mass generally peaks in the third
decade of life and thereafter slowly decreases.21 Regular exercise can prevent or slow
bone loss by building strength in the muscles to improve coordination and balance as well
as reduce the prevalence of falls and fractures.21 The best form of exercise to increase
bone density is weight-bearing activities due to the increased work against gravity.21
Examples of weight-bearing activities include walking, jogging, and climbing stairs.
Non-weight bearing activities, such as swimming and most bicycling activities, are still
beneficial in producing cardiovascular benefits; however, they do not increase bone
density.21
Engagement in regular exercise will result in increased muscle mass also known
as lean body mass as well as increased muscular strength.1 Increases in muscle mass and
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strength are beneficial for several reasons. More muscle mass means an increased
metabolism as muscle burns more calories than fat, muscle naturally burns more calories
than fat in order to maintain proper functional capability, and an increased muscle
strength leads to a reduction in injuries and improves balance.1 Finally, increases in both
muscle mass and strength also help improve mood and better sleep due to increases in
energy from the extra calories burned compared to fat calories.1

Exercise Guidelines for Weight Loss
The American College of Sports Medicine (ACSM) states that energy expenditure
must exceed energy intake for weight loss to occur; in basic terms, individuals must burn
more calories than they eat to lose weight.1,20,21 There are three methods for achieving
this negative caloric balance and weight loss: (1) consume fewer calories, (2) expend
more calories, or (3) a combination of consuming fewer and expending more calories.
Exercise plays a key role in methods 2 and 3.
ACSM has published exercise prescription guidelines for weight loss and
maintenance.1 These guidelines are based on the amount of energy it takes to perform
various physical activities. Metabolic Equivalents (METs) are a physiological measure
used to express the energy cost of physical activity and are used by exercise physiologists
to determine what activities are appropriate for individuals given their current
cardiovascular fitness level.1 For example, one MET equals the amount of energy
expended at rest, light intensity training is considered as 1.1 - 2.9 METs, moderate
training intensity as 3.0 - 5.9 METs, and vigorous training intensity as ≥ 6 METs.1,20,22 A
higher MET level indicates an increase in energy cost resulting in a greater caloric
expenditure and potential weight loss. Research has also shown that every 1-MET
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increase in aerobic capacity resulted in a 13% decrease in all-cause mortality and a 15%
decrease in cardiovascular events.20
All training prescriptions follow a general program, often referred to as FITT
(frequency, intensity, time, and type). Following the FITT principle, frequency refers to
how often an exercise routine is performed each week. It is recommended to exercise five
or more days per week.1 Intensity represents the force or effort used during exercise. A
moderate-to-vigorous intensity level, which could also be described as 40 – 60% heart
rate reserve (HRR), is recommended to enhance cardiovascular health.1 The first T in
FITT indicates how much time should be spent in an exercise session. Each exercise
session should last 30 – 60 minutes per day for a minimum of 150 minutes per week and
progress to 300 minutes per week.1 It is also effective to accumulate intermittent
exercises of at least 10 minutes before progressing to a continuous bout of 30 – 60
minutes of exercise.1 Accumulated exercise time is sometimes recommended for
individuals who are just starting with a new exercise program to help build a baseline of
cardiovascular fitness.1 Finally, the last T in FITT refers to the type of activity and should
include a balanced program of cardiovascular and resistance training exercises.1
Specific exercise guidelines have also been established for overweight and obese
populations. Based on these guidelines, it is recommended that individuals who are
overweight or obese try to exercise five to seven days per week with intensity levels at a
moderate level, which would equate to 40 – 60% heart rate reserve (HRR).1 It has been
suggested that emphasis should be placed on duration and frequency rather than intensity;
therefore, the ACSM has recommended that obese individuals gradually work towards 45
to 60 minutes of exercise. Longer durations of exercise at lower intensities have been
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shown to shift from a glycogen fuel source to fat stores after 30 minutes. For long-term
weight loss and weight management, it has been emphasized that obese individuals
exercise for a total of 250-300 minutes per week.1 Accumulated exercise broken into 10minute sessions is recommended for obese individuals who were previously sedentary
and are just starting a new exercise program.1 Finally, the type of activity should include
a balanced program of cardiovascular and resistance training exercises.1
The ACSM position stand on weight loss states that a safe level of weight loss is
about 1-2 kg/week (2-3 pounds).22 The National Strength and Conditioning Association
(NSCA) recommends “an initial weight loss goal of 5-10% body weight over the course
of six months and defines successful weight maintenance as a weight regain of ≤ 3 kg in
two years and sustained reduction in waist circumference of at least four cm.”2(p.47)
Elements of weight loss involves body composition, which is made up of lean mass (LM)
and fat mass (FM). Lean mass consists of bones, organs, and muscles whereas fat mass
consists of fat only.1 Body fat percentage can be calculated using the amount of LM and
the amount of FM to determine the percent of FM on the body. In terms of losing weight,
fat mass (FM) can be changed the most, with variability of body fat range from 6-60% of
total body weight.23,24 The recommended body fat percentage for men ranges between
10% - 22%, and the recommended body fat percentage for women ranges between 20% 32%.1
An additional way to determine body composition is the use of the Body Mass
Index (BMI). BMI is used to assess gender-specific weight relative to height and is
calculated as weight (in kilograms) divided by height (in meters) squared.1 The
classifications for BMI are underweight < 18.5 kg/m2, normal 18.5-24.9 kg/m2,
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overweight 25.0-29.9 kg/m2, obesity class I 30.0-34.9 kg/m2, obesity class II 35.0-39.9
kg/m2, and obesity class III ≥ 40.0 kg/m2.1 Although BMI fails to discern between lean
mass, fat mass, or bone, a BMI of ≥ 30.0 kg/m2 is still associated with increased risks of
hypertension, sleep apnea, Type 2 diabetes, CVD, and higher mortality rates.1
Finally, the ACSM emphasizes the difference between physical activity (PA) for
exercise and PA for lifestyle. PA for exercise would be described as planned activity for a
specific period of time, such as walking at a moderate to fast pace for 30 - 60 minutes,
while lifestyle PA would be described as physical activity that is performed as part of
daily living such as walking to work or taking the stairs instead of the elevator.22 While
increasing lifestyle PA each day will not result in great amounts of weight loss, a
combined effort of exercise and diet (energy restriction), resulting in a negative energy
balance, have been shown to result in the greatest amount of weight loss.22,25

Weight Loss Programs
There have been numerous studies addressing weight loss programs for those
individuals who are obese. One study demonstrated that obese individuals experienced
successful weight loss as a result of an increase in exercise, an altered diet, and the use of
weight loss medications.12 Successful weight loss was determined when obese individuals
maintained the weight that was lost for a minimum of one year.12 In this study, exercise
was shown to be strongly associated with successful weight loss compared to diet and
weight loss medications alone. This was not to say that diet was not important, but that
diet alone was not sufficient in producing successful weight loss when compared to
exercise. This research demonstrated that diet and exercise were useful tools in terms of
losing weight, especially when used in conjunction with each other. Other weight loss
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outcomes found with this self-reported study was that the participants lost more weight
when they ate less fat, exercised more, and followed commercial weight loss diets.12
Research defines successful weight loss in obese individuals to be 10% or more of
their initial body weight and weight maintenance for more than one year.12,26 Most weight
loss studies were three to six months in length with a one year follow-up to determine the
amount of weight loss and weight maintenance.12,26,27 Also, most studies included selfreported measures of physical activity.12,26,27 One study looked at the rate of initial weight
loss to determine a safe and effective weight loss program. The study divided participants
into three groups: a slow weight loss group, a moderate weight loss group, and a fast
weight loss group.26 The slow group consisted of weight loss equal to or less than 0.5
pounds per week, the moderate group consisted of weight loss between 0.5-1.5 pounds
per week, and the fast group consisted of weight loss more than or equal to 1.5 pounds
per week. Statistically, the fast, moderate, and slow weight loss groups did not
significantly differ from each other (p < 0.05) in terms of weight loss maintenance. Even
though all three methods were effective in producing weight loss, the slow and moderate
weight loss groups were found to be the safest in terms of overall health.26
It has been found that long-term regular physical activity contributes to successful
weight maintenance. Long-term physical activity over a 10 year period has been to
shown to limit the amount of weight regained that occurs with aging.25 Specifically, it
was demonstrated that increases in intensity, time, and the number of exercise sessions
per week were related to less weight regain in individuals over 45 years of age.25 In
addition, these FITT principle results had a greater association with women over men,
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and that obese individuals experienced greater changes when compared to normal weight
counterparts.25
Successful weight loss in obese individuals has also been reported when
participants outlined their anticipated results and recorded daily physical activity levels
and diet diaries. A behavioral weight loss program was used to research weekly
fluctuations in self-monitoring, outcome expectancies, difficulties with eating, and
exercise.28 The study included 40 obese participants who completed a six-month
behavioral weight loss program where body weight, outcome expectancies, and
difficulties with eating and exercise were measured weekly. Exercise and food diaries
were utilized for the participants to log their physical activity and caloric intake. The
results of this study showed that participants lost more weight during weeks where they
reported positive outcome expectancies (expected results based on several health
behavior change models) compared to weeks where they reported negative outcome
expectancies.28 The weeks in which participants experienced greater exercise frequency
and weight loss were those in which they were consistent with self-monitoring exercise in
their physical activity diary; this frequency was almost twice as much weight lost as
when they were not consistent with self-monitoring. At the end of the six-month
behavioral weight loss program, the participants lost an average of 7.6 kg (7% decrease, p
< 0.05), increased their cardiovascular fitness level by 17.6% using a submaximal graded
exercise test before and after the program, increased their duration of exercise on the
treadmill by 78 minutes per week, and decreased their self-reported caloric intake by 776
calories per day (32% decrease, p < 0.05).28 In addition, reassuring the participants that
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regular exercise may not show detectable weekly changes but will benefit the patients in
the long-term, was used to help with increased positive outcome expectancies.

Anti-Gravity Exercise
Often times, obese individuals exhibit a resistance to exercise due to a
combination of musculoskeletal and orthopedic limitations, especially while walking.
Limitations are often in the form of increasing pain, swelling, and subsequent gait
changes.1,29 There are some exercises that reduce the gravitational forces (anti-gravity)
placed on the body while doing weight-bearing activities. Swimming, or even walking in
a pool, is one such anti-gravity activity that can reduce loads on the musculoskeletal
system. It has been shown that walking in the pool can reduce lower extremity pain and
allow obese individuals to sustain longer bouts of exercise.14 Unfortunately, exercising in
a pool is considered a non-weight bearing activity and does not substantially contribute to
bone density or structure.14
Conversely, walking on treadmills is often seen as a popular weight-bearing
exercise device and positively affects bone mineral density and structure.14
Unfortunately, a traditional treadmill does not reduce the load placed on an individual’s
lower extremities, which could contribute to musculoskeletal issues or orthopedic
limitations of obese individuals who use a treadmill to walk. To help minimize the load
on the body while walking, several adaptations to treadmills have been made. In one
study, an independent harness was constructed on a traditional treadmill for patients as
way of decreasing loads in order to heal tissues, conserve energy, and reduce pain.15
Harness supported treadmills allowed individuals to rehabilitate injuries within their
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functional capacity at lower energy cost, yet still produced significant cardiovascular
conditioning.15
Partial body weight support using a suspended harness on a treadmill (LiteGait) is
common in rehabilitation. One study investigated the use of a LiteGait system to
determine the effects of suspended walking on gait patterns based on Froude number
results.30 The Froude number is a dimensionless ratio derived from a traditional walking
model. The model uses an inverted pendulum to compare the contribution of forces from
body inertia and gravity that demonstrates that the gravitational force is greater than the
centrifugal forces in keeping the foot in contact with the ground.30 Froude numbers are
used in supported treadmill walking to determine the amount of unloading needed to
reach an appropriate treadmill speed for rehabilitation. For example, a Froude number of
0.5 represents the change in gait from walking to running, whether the person is on the
earth or on the moon.30 The findings from this study indicated that gait patterns were
affected by body weight unloading while walking in the LiteGait.30
Further attempts at developing a treadmill device to reduce load, yet maintain
weight-bearing benefits, were conducted by the National Aeronautics and Space
Administration (NASA). Differential Air Pressure (DAP) was used to “weight” an
individual harnessed into an enclosed treadmill.16 The lower body negative pressure
(LBNP) created inside the walking chamber simulated the gravity-induced fluid shifts so
that the astronauts could maintain cardiovascular function and bone density while in
space.16
Based on the advances made by NASA on LBNP, the AlterG Company reversed
the negative pressure to positive pressure (Lower Body Positive Pressure – LBPP) to
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reduce weight in normal gravity situations found on Earth.17 The AlterG Anti-Gravity
Treadmill was developed to accommodate LBPP (see Figure 2.1) and has been shown to
increase proper gait mechanics, proper muscle firing and recruitment, as well as reducing
heart rate in the rehabilitation setting.17 As part of a previously mentioned study
regarding the LiteGait,30 it was found that using a LBPP device was more closely aligned
with unsupported gait mechanics, compared to the LiteGait. The research supported the
use of LBPP device (AlterG Anti-Gravity Treadmill), not only for rehabilitative events,
but also for individuals in a weight loss program. In addition, the AlterG Anti-Gravity
Treadmill has allowed obese individuals to walk at lower percentages of their body
weight by using LBPP to decrease the incidence of musculoskeletal pain and gait
abnormalities that are typically seen in obese individuals.17
Further research has studied the effects of LBPP and the use of the AlterG AntiGravity Treadmill. One researcher looked at the changes in velocity and amount of
weight support on ground reaction forces (GRFs) using the AlterG Anti-Gravity
Treadmill and found that by changing the velocity and the amount of weight support,
cardiovascular fitness levels could be maintained.31 This study consisted of 17 trials over
two experimental sessions in a university research laboratory. The participants completed
nine trials during session one and eight trials during session two with each session being
seven minutes in length.31 Based on those findings, the AlterG Anti-Gravity Treadmill
was found to be a beneficial exercise device for those individuals who had orthopedic
limitations or excess body weight.31
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Figure 2.1

Illustration of LBPP in AlterG Anti-Gravity Treadmill 32

Another study looked at the effects of a LBPP device to produce weight loss in
women.33 The authors compared four groups of 20 women, which consisted of a
traditional physical activity group (C), a diet only group (D), a diet and exercise group
(DE), and a diet, exercise, and LBPP group (DEP) over a period of 12-weeks. The
protocol for the two exercise groups was endurance-based training with 30 minutes of
cycling at 50% of the participants V̇O2max, three times a week. A HypoxiS 120 LBPP
device (comparable to a bicycle ergometer) was used for the DEP group. HypoxiS 120
training was also utilized in the DE group without the lower body pressure activated.
Diets and exercises were constant throughout the appropriate groups. The data collected
during the intervention were heart rate (Polar heart rate monitor), body weight, waist
circumference, and resting metabolic rate (RMR). Indirect calorimetry was used to
measure RMR, which was used to determine the participants’ energy requirements and to
calculate a negative energy balance. The DEP group lost 16.1% total body fat, the
exercise and diet group lost 13.5% total body fat, the diet only group lost 7.8% total body
fat, and the control group lost 1.5% total body fat across the 12-week intervention.33 It
was concluded that while the diet and exercise groups, as well as the LBPP groups,
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produced significant weight loss, the LBPP showed the most significant weight loss
(16.1%) because the LBPP is thought to increase the mobilization of extracellular
water.33 Extracellular water consists of interstitial fluid and plasma found outside of the
cells and produces an unwanted cosmetic appearance in the form of cellulite, especially
for women.33 The LBPP also showed an increase in peripheral blood flow, which the
authors speculated could benefit individuals with circulatory disorders, wound healing, or
lymphedema.33
There have been case studies researching the effectiveness of the AlterG AntiGravity Treadmill on various post-operative and lower extremity injuries such as ACL
reconstruction, stress fractures, and joint replacements. One case study used the AlterG
Anti-Gravity treadmill to determine the effects of a 14-week walking program with a
morbidly obese individual.34 The participant walked on the treadmill three times per
week, and exercise intensity was kept between 40-60% of the participant’s heart rate
reserve. Initially, the exercise sessions included a five minute warm-up and cool-down
and 10 minutes of walking. Duration increased to 65 minutes by the end of the study and
was based on the participant’s exercise tolerance and response. The researchers found
that the walking program improved the participant’s physical activity and exercise
tolerance levels, but was insufficient to produce significant weight loss.34 It was
suggested that if the participant’s exercise tolerance improved and the amount of LBPP
was reduced, that more weight loss would have resulted. More research is still needed in
looking at exercise-induced weight loss programs with the AlterG Anti-Gravity Treadmill
for obese individuals.
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Conclusion
In conclusion, it is clearly evident that exercise plays a critical role in weight loss
and successful weight maintenance. Long-term physical activity has been shown to be the
best source for weight change and weight maintenance. The use of LBPP treadmills have
been shown to increase proper gait mechanics, proper muscle firing and recruitment in
the lower extremities, as well as reducing heart rate in the rehabilitation setting. LBPP
has also been found to be effective in maintaining cardiovascular fitness benefits while
training in the device. Finally, the AlterG Anti-gravity treadmill appears to be a
promising device to use by obese individuals who may benefit from decreased exercise
loads as part of an exercise walking program.
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CHAPTER THREE: METHODS AND PROCEDURES

This chapter will describe the participants and volunteer process for this study,
along with the methods and procedures used in data collection. Finally, an explanation of
data analyses will be provided.

Participants
Initially, 17 individuals volunteered to participate in the 18-week study. At the
conclusion of the study, 15 volunteers (3 males; 12 females), ranging in age from 18-55
years (Mean ± SD; 41.29 years ± 7.82 years), completed the intervention and assessment
periods for the data analysis. Participants were randomly assigned to the AlterG AntiGravity Treadmill group (AlterG; n = 6) and the traditional treadmill group (TT; n = 9).

Recruitment
Prior to beginning the study, the weight loss protocol underwent review and
approval from the Boise State University Institutional Review Board (IRB) (see
Appendix A). Upon approval, participants were recruited from the following programs
and locations: Boise State University Kinesiology Department and Student Recreation
Center, Boise YMCA centers, Boise Axiom Fitness clubs, Boise Engage Wellness clubs,
and St. Luke’s Wellness Program. Phone calls, emails, flyers, and word of mouth were
used to advertise the need for participants at these various locations (see Appendix B).
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Randomization
Participants first contacted the researcher if they were interested in enrolling in
the study. Based on that contact, each volunteer was assigned an ID number, and was
placed within a randomized treadmill grouping list generated using SPSS 21.0 where
each ID corresponded to a random grouping number 1 (= AlterG Anti-Gravity Treadmill
Group [AlterG]) or 2 (= Traditional Treadmill Group [TT]). For example, if a volunteer’s
ID number was six and the corresponding grouping number was two, then this volunteer
would be assigned to the TT group. This process continued until the researcher received
no further volunteer contacts.
Each participant was then scheduled for an orientation visit, which lasted
approximately 2 hours. If the participant was excluded from the study based on the
orientation visit, their name was removed off the randomized grouping list, and the next
volunteer participant to contact the researcher was placed in the open slot. This process
was continued until the researcher met with all of the participants who initially expressed
interest in the study.

Orientation Visit
During the orientation visit, each participant was asked to complete the Informed
Consent Form (see Appendix C) after the study protocol and procedures were discussed
and any/all questions were answered. As part of the informed consent, participants were
assured that they would have individual exercise sessions and would not be aware of
other participants in the study. Individual status and progress during the training program
would only be discussed with the participant and the lead researcher involved in the
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study. All of the participant data would be entered into the computer and recorded using
an ID code to ensure confidentiality
During the orientation visit, participants completed the Health History
Questionnaire1 to determine medical history such as, diseases, smoking history,
medications, and allergies (see Appendix D). Based on the questionnaire results,
participant risk was stratified as low, moderate, or high risk following ACSM’s
guidelines for pre-participation health screening and risk stratification.1 Participants were
excluded if they were of high risk in the risk stratification per ACSM guidelines.1,22
•

Low Risk: Asymptomatic men and women who have ≤1 CVD risk factor.

•

Moderate Risk: Asymptomatic men and women who have ≥2 risk factors.

•

High Risk: Individuals who have known cardiovascular, pulmonary, metabolic
disease, or one of more signs and symptoms.
Those participants who were of low or moderate risk were then furthered asked to

complete a Numeric Pain Scale (NPS) form for lower extremity pain (see Appendix E)
and were measured for height and weight to determine BMI, along with skin fold and
body circumference measurements.

Equipment and Measurements
Two treadmills were used during this study: (1) the AlterG Anti-Gravity
Treadmill (model P200, AlterG, Inc. Fremont, CA), and (2) the Woodway Treadmill
(model Desmo Hp, Woodway USA, Inc. Waukesha, WI). The Woodway treadmill is a
traditional treadmill common to many fitness facilities. The AlterG Anti-Gravity
Treadmill requires all users to calibrate the treadmill prior to use. Each time the AlterG
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treadmill was used, it was calibrated for that specific participant. The Woodway treadmill
was calibrated per the manufacturer settings and was not changed throughout the duration
of the weight loss intervention. Both of the treadmills were located in the Human
Performance Laboratory at Boise State University.
Several formative and summative measurements were collected and recorded as
part of this research. The following measurements were taken at baseline, during the
study, and at the conclusion: body weight, skinfold, waist-to-hip ratio, calf
circumference, heart rate, blood pressure, Rating of Perceived Exertion (RPE), Numeric
Pain Scale (NPS), and steps walked per day. The participant’s body weight was measured
at baseline and at week 6, 12, and 18 with the use of a digital Tanita scale (model BWB
800, Tanita Corporation, Tokyo, Japan). The participant’s weight was also monitored
before each exercise session to follow the safe exercise weight loss guidelines as
presented by the ACSM.1
Skin fold measurements were collected at baseline as well as week 6, 12, and 18.
Body fat percentage was calculated using the Jackson-Pollock 7-site skinfold protocol,
which includes chest, axilla, triceps, subscapular, abdominal, suprailiac, and thigh sites.1
The lead researcher took all measurements at all points of the study to ensure reliability.
A heart rate monitor (model FT1, Polar Electro Oy, Oulu, Finland) was used
during treadmill walking to monitor exercise intensity and target heart rate training zones,
per the guidelines established in the weight loss protocol. Blood pressure, using a manual
stethoscope and blood pressure cuff (Prosphyg Aneroid Sphygmomanometer, ADC,
Hauppauge, New York), was measured during and after each exercise session to ensure
an appropriate exercise and recovery response.1
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Along with monitoring the target heart rate training zone, the RPE, using the
modified Borg 1-10 scale, where 1 represents no work and 10 represents working as hard
as possible, was used to indicate subjective perception of exercise intensity.19 The RPE
scale was shown to the participants once they reached steady state of the walking
protocol during each exercise session, and their response was recorded. An appropriate
RPE was maintained for each training phase of the weight loss protocol.
To monitor lower body pain, the NPS was used to describe the level of pain in the
lower extremities that the participants were experiencing while walking on the
treadmills.18 The NPS is a numbered scale labeled from 0-10, with zero being no pain and
10 the most intense pain imaginable. The participants verbally reported what number
best represented the level of pain they were experiencing. This pain scale was recorded at
the beginning of the session, before and after each exercise session, and at the end of the
session. The NPS has been proven to be a valid and reliable scale to assess pain.18
To monitor physical activity (PA) level outside of the exercise sessions,
DigiWalker pedometers (SW200, Yamax, Japan) were used to calculate overall step
counts per week. Other than removing the pedometer during treadmill walking sessions,
participants were asked to wear the pedometer every day of the week, from the time they
woke up to the time that they went to bed. The pedometer was placed on the mid-axillary
line of their waistband. Participants were then asked to walk 10 steps to confirm the
accuracy of the pedometer steps. If the pedometer was not within one step of the actual
steps, the pedometer was moved to the back of the waistband and the test was completed
again. Some of the participants, due to excessive waist circumference, moved the
pedometer to the middle of their lower back to maintain a more vertical position.35
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Participants were told not to wear the pedometer in any water activity as the pedometers
were not waterproof. The participants kept a log of their steps each day and turned in
their log once a week to the lead researcher for documentation. Finally, participants were
reminded to maintain their normal daily routines throughout the study. For a summary
schedule of all collected measurements, see Table 3.1.
Table 3.1

Summary of Measurements

Measurements Baseline

Body Weight

Yes

BMI

Before

During

After

Week 6

Exercise

Exercise

Exercise

and 12

Yes

Post

Yes

Yes

Yes

Yes

Yes

Skinfold

Yes

Yes

Yes

Heart Rate

Yes

Yes

Yes

Yes

Yes

Yes

Blood

Yes

Yes

Yes

Yes

Yes

Yes

RPE

Yes

Yes

Yes

Yes

Yes

Yes

NPS

Yes

Yes

Yes

Yes

Yes

Yes

Pressure

Pedometer

Yes

Yes

Weight Loss Protocol

Exercise Sessions
The weight loss protocol was an 18-week walking intervention wherein three
exercise sessions were completed per week. The intervention was broken down into three
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6-week phases: immediate, intermediate, and advanced. Target heart rates and training
zones were calculated using the participant’s age predicted maximum heart rate, as
established by the ACSM.1 The training zones, 20-85% of age predicted heart rate
maximum, were determined by the guidelines listed in the weight loss protocol. The
participants wore a heart rate monitor to ensure proper training intensity within each
phase of the weight loss protocol.1,22 The following outlines the protocol followed for
each phase of the study.

Phase 1: Immediate 1-6 Weeks

Phase Goals
•

Began weight loss program

•

Monitored heart rate, blood pressure and Rating of Perceived of Exertion (RPE)
throughout

•

Aimed for 30 minutes of physical activity 3 days a week, either continuously or at
regular intervals of at least 10 minutes duration as tolerated by the participant

•

Physical activity began at a mild to moderate intensity, target heart rate = 20-40%
of age predicted heart rate maximum; calculated by: (206.9 – (0.67 x age)) x 20
and 40% respectively.1 RPE should be low, 1-3 on a modified Borg scale of 1 –
10

AlterG Anti-Gravity Treadmill Exercise
Physical activity began at a mild-to-moderate intensity. The participant walked at
50-70% of their effective body weight (as adjusted on AlterG Anti-Gravity Treadmill) at
1.5-3.5 mph for 30 minutes. All participants began walking at 50% of their effective body
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weight and were progressed individually based on fitness and comfort level. The AlterG
Anti-Gravity Treadmill had the participant enclosed in a waist-high pressure chamber
that inflated or deflated to reach the desired weighted percentage. Weight percentage was
determined with the AlterG Anti-Gravity Treadmill by the pressure produced by the
participant standing on a force plate under the belt of the treadmill and from that
determined how much to inflate or deflate when the desired weighted percentage was
selected. Once a comfortable walking speed had been established and heart rate was
below the target zone, the treadmill incline was increased to bring the heart rate into the
target zone. As the individual adapted, the training program was progressed each session
to allow pain free physiological adaptations to continue by increasing one of the
following: body weight, exercise intensity (speed and/or grade) by 1-5% as tolerated.
When increasing exercise intensity, the participant’s heart rate was kept in the target HR
zone and an RPE range of 1-3.1,22

Woodway Treadmill Exercise
Physical activity began at a mild-to-moderate intensity. The participant walked at
1.5-3.5 mph for 30 minutes. Once a comfortable walking speed had been established and
heart rate was below the target zone, the treadmill incline was increased to bring the heart
rate into the target zone. As the individual adapted, the training program was progressed
each session to allow pain free physiological adaptations to continue by increasing one of
the following: exercise intensity (speed and/or grade) by 1-5% as tolerated. When
increasing exercise intensity, the participant’s heart rate was kept in the target HR zone
and an RPE range of 1-3.1,22
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Phase 2: Intermediate 6-12 weeks

Phase Goals
•

Continued weight loss program

•

Monitored heart rate, blood pressure and RPE as previously described

•

Aimed for 45 minutes of physical activity 3 days a week, either continuously or at
regular intervals of at least 10 minutes duration as tolerated by the participant

•

Physical activity was at a moderate intensity, 40-60% of age predicted heart rate
maximum; calculated by: (206.9– (0.67 x age)) x 40 and 60% respectively.1 RPE
was moderate, around 3-5

AlterG Anti-Gravity Treadmill Exercise
Physical activity was at a moderate intensity. The participant walked at 70-80% of
their effective body weight for 45 minutes, as adjusted on the AlterG Anti-Gravity
Treadmill. The participant achieved target heart rate by walking at 2.5-4.0 mph. Once a
comfortable walking speed had been established and heart rate was below the target zone,
the treadmill incline was increased to bring the heart rate into the target zone. When
increasing exercise intensity, the participant’s heart rate and RPE was kept in the target
zone as previously discussed.1,22

Woodway Treadmill Exercise
Physical activity was at a moderate intensity. The participant achieved target heart
rate by walking at 2.5-4.0 mph for 45 minutes. Once a comfortable walking speed had
been established and heart rate was below the target zone, the treadmill incline was
increased to bring the heart rate into the target zone. When increasing exercise intensity,
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the participant’s heart rate and RPE was kept in the target zone as previously
discussed.1,22

Phase 3: Advanced 12-18 Weeks

Phase Goals
•

Continued weight loss program

•

Monitored and teach heart rate, blood pressure and RPE as previously described

•

Aimed for 60 minutes of physical activity 3 days a week, either continuously or at
regular intervals of at least 10 minutes duration as tolerated by the participant

•

Physical activity was at a moderate to vigorous intensity, 60-85% of age predicted
heart rate maximum, calculated by: (206.9 – (0.67 x age)) x 60-85% respectively.1
RPE was moderate to slightly vigorous, around 5-7

AlterG Anti-Gravity Treadmill Exercise
Physical activity was at a moderate-to-vigorous intensity. The participant fast
walked/light jogged at 80-95% of their effective body weight for 60 minutes, 4.0+ mph or
by increasing the incline on the AlterG Anti-Gravity Treadmill to 3-5% as tolerated and
adjusted on the AlterG Antigravity Treadmill. Once a comfortable walking speed had
been established and heart rate was below the target zone, the AlterG Anti-Gravity
Treadmill incline was increased to bring the heart rate into the target zone. When
increasing exercise intensity, the participant’s heart rate and RPE was kept in the target
zone as previously discussed.1,22
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Woodway Treadmill Exercise
Physical activity was at a moderate-to-vigorous intensity. The participant fast
walked/light jogged for 60 minutes, 4.0+ mph or by increasing the incline to 3-5% as
tolerated and adjusted on the Woodway Treadmill. Once a comfortable walking speed
had been established and heart rate was below the target zone, the incline was increased
to bring the heart rate into the target zone. When increasing exercise intensity, the
participant’s heart rate and RPE was kept in the target zone as previously discussed.1,22

Data Analysis
Weight, BMI, and body fat percentage from the beginning to the end of the
intervention were analyzed to evaluate the success of the program. All collected data
were logged into an Excel spreadsheet throughout the duration of the weight loss
program. Data were analyzed using SPSS, version 21.0 (SPSS Inc., Chicago, IL).
Descriptive statistics were carried out for body weight, BMI, body fat percentage,
average steps per day, NPS scores, and compliance rates. Separate 2 (treadmill group) x 4
(time) repeated measures ANOVA, where group is the between subject independent
variable and time is the within group variable, was conducted to determine whether
statistical significant differences existed for the multiple dependent variables (e.g.,
weight, BMI, and body fat percentage) from beginning to end of the study. If significance
was found, a Least Significant Difference (LSD) post-hoc test was used to determine
which specific phases of the study were significant.
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CHAPTER FOUR: RESULTS

Participants
Fifteen obese participants, aged 42.73 ± 7.03 years old with a BMI ≥ 30 kg/m2,
completed the walking program and were included in the final data analyses. Participants
were randomly assigned to either the AlterG Anti-Gravity Treadmill group or Traditional
Treadmill group (see Table 4.1).
Table 4.1

Description of Gender, Age, Height, and Weight

Group

Age (years)

Height (cm)

Weight (kg)

n

Mean ± SD

Mean ± SD

Mean ± SD

Males

1

36.00

172.72

101.70

Females

5

43.20 ± 8.12

162.30 ± 9.91

91.22 ± 17.08

Total

6

42.00 ± 7.87

164.04 ± 9.18

92.97 ± 15.87

Males

2

41.00 ± 8.49

187.33 ± 11.67

118.55 ± 10.11

Females

7

43.86 ± 6.96

166.01 ± 6.34

114.03 ± 21.62

Total

9

43.20 ± 6.85

170.75 ± 11.64

115.03 ± 19.17

15

42.73 ± 7.03

168.06 ± 10.91

106.21 ± 20.62

AlterG Group

TT Group

Total
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Effects of the Walking Intervention

Weight
The average weight for all of the participants prior to the start of the weight loss
intervention was 105.24 kg ± 19.66 kg (Mean ± SD). There was a statistically significant
difference for weight between the AlterG and TT groups at baseline, p = 0.024. By the
end of the weight loss intervention, the average weight for all of the participants was
102.92 kg ± 21.02 kg. For the AlterG group, the baseline average weight was 92.97 kg ±
15.87 kg and the post average weight was 90.63 kg ± 13.47 kg. For the TT group, the
baseline average weight was 115.03 kg ± 19.17 kg and the post average weight was
113.44 kg ± 21.27 kg. The average amount of weight loss in kilograms for all participants
was 2.2 kg, and the average percent change of weight loss in kilograms was 2.0%. The
AlterG group lost an average of 2.3 kg (2.19%) compared to the TT group that lost an
average of 2.1 kg (1.83%) (see Figure 4.1).
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Weight (kg)

115

a

c,d

d

a,c

110
105

AlterG

100

TT

95

b

c,d
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d

b,c
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Figure 4.1

6 Week

12 Week

18 Week

Body Weight (kg) for All Participants by Treadmill Group

Note. Same subscripts differ significantly among groups and weeks at p < 0.05.
a
AlterG Baseline and Post; bTT Baseline and Post; c,dWeek difference
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There was a significant difference between the two treadmill groups, F (1, 11) =
4.60, p = 0.055, eta squared = 0.295, observed power = 0.499. The participants in the TT
group always had a higher weight compared to the AlterG group. There was a significant
difference among the three phases of the weight loss intervention, F (1.35, 14.89) = 5.59, p =
0.024, eta squared = 0.337, observed power = 0.675. The participants at baseline and at
week 6 of the weight loss intervention had a higher weight when compared to week 12
and week 18 of the weight loss intervention. A Least Significant Difference (LSD) posthoc test revealed a significant weight difference between week 6 and week 12 (p = 0.002)
and between week 6 and week 18 (p = 0.016). There was not a significant interaction
between the two treadmill groups and the intervention phases on body weight, F (1.35, 14.89)
= 0.11, p = 0.822, eta squared = 0.010, observed power = 0.062. Both groups responded
to the weight loss intervention similarly, and participant weight loss was similar between
both the AlterG group and the TT group (see Table 4.2).

Body Mass Index
The average BMI for all of the participants prior to the start of the weight loss
intervention was 37.09 kg/m2 ± 5.42 kg/m2. There was a significant difference found for
BMI between the AlterG and TT groups at the beginning of the study, p = 0.041. At the
end of the weight loss intervention, the average BMI for all of the participants was 36.06
kg/m2 ± 5.34 kg/m2. For the AlterG group, the baseline average BMI was 34.32 kg/m2 ±
2.69 kg/m2 and the post average BMI was 33.52 kg/m2 ± 2.06 kg/m2. For the TT group,
baseline average BMI was 39.57 kg/m2 ± 6.25 kg/m2 and the post average BMI was 38.22
kg/m2 ± 6.46 kg/m2 (see Figure 4.2).
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Table 4.2

Weight and Body Composition Averages by Treadmill Group
Baseline

Week 6

Week 12

Week-18 Post

Variable

Group

n

Mean ± SD

Mean ± SD

Mean ± SD

Mean ± SD

Weight

AlterG

6

92.97 ±

92.92 ±

91.62 ±

90.63 ±

15.87a

15.02 c,d

14.28 d

13.47a,c

115.03 ±

114.98 ±

113.51 ±

113.44 ±

19.17b

19.31c,d

19.36d

21.27b,c

34.32 ±

34.33 ±

33.87 ±

33.52 ±

2.69a,c,d

2.42e,f

2.29c,e

2.06a,d,f

39.57 ±

39.54 ±

39.01 ±

38.22 ±

6.25b,c,d

6.22e,f

6.08c,e

6.46b,d,f

36.64 ±

35.49 ±

34.38 ±

32.79 ±

3.61a,c

3.82c

4.54c

4.55a,c

36.57 ±

35.62 ±

34.70 ±

33.44 ±

4.72b,c

4.89c

4.91c

5.77b,c

(kg)
TT

BMI

AlterG

9

6

(kg/m²)
TT

BF (%)

AlterG

TT

9

6

9

Note. Means ± SD with same subscripts differ significantly among groups and weeks at p
< 0.05.
a
AlterG Baseline and Post
b
TT Baseline and Post
c,d,e,f
Week difference

38
45

Body Mass Index (kg/m²)

43
41
a,c,d

39

e,f

c,e
a,d,f

AlterG

37

TT

35

b,c,d

e,f

c,e

33

b,d,f

31
29
Pre

Figure 4.2

6 Week

12 Week

18 Week

Body Mass Index (kg/m2) for All Participants by Treadmill Group

Note. Means ± SD with same subscripts differ significantly among groups and weeks at p
< 0.05.
a
AlterG Baseline and Post
b
TT Baseline and Post
c,d,e,f
Week difference

There was no statistical difference found between the two treadmill groups, F (1,
11) =

2.48, p = 0.144, eta squared = 0.184, observed power = 0.301. There was a

significant difference among the three phases of the weight loss intervention, F (1.34, 14.73)
= 5.90, p = 0.021, eta squared = 0.349, observed power = 0.695. The participants at
baseline and at week 6 of the intervention had a higher BMI when compared to week 12
and 18 of the intervention. A LSD post-hoc test revealed a significant difference between
baseline and week 12 (p = 0.044), between baseline and week 18 (p = 0.043), between
week 6 and week 12 (p = 0.003), and between week 6 and week 18 (p = 0.017). There
was not a significant interaction between the two treadmill groups and intervention
phases on BMI, F (1.34, 14.73) = 0.13, p = 0.793, eta squared = 0.012, observed power =
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0.065. Both groups responded to the weight loss intervention similarly and participant
BMI loss was similar between both the AlterG group and the TT group (see Table 4.2).

Body Fat Percentage
The average body fat percentage (BF) for all of the participants at the start of the
study was 36.49% ± 4.09%. There was no statistical difference for BF between the
AlterG and TT groups, p = 0.932. By the end of weight loss intervention, the average BF
was 33.14% ± 5.04%. For the AlterG group, the baseline average BF was 36.64% ±
3.61% and the post average BF was 32.79% ± 4.55%. For the TT group, baseline average
was 36.57% ± 4.72% and the post average was 33.44% ± 5.77% (see Figure 4.3).

Body Fat Percentage (%)

39
37
a,c

35

b,c
c
c

c
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a,c
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Figure 4.3

6 Week

12 Week

18 Week

Body Fat Percentages (%) for All Participants by Treadmill Group

Note. Means ± SD with same subscripts differ significantly among groups and weeks at p
< 0.05.
a
AlterG Baseline and Post
b
TT Baseline and Post
c
Week difference
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There was no statistical difference in BF percent between the two treadmill
groups, F (1, 11) = 0.01, p = 0.920, eta squared = 0.001, observed power = 0.51. There was
a significant difference found among the three phases of the weight loss intervention, F
(1.34, 14.69) =

67.05, p < 0.0005, eta squared = 0.859, observed power = 1.000. The

participants at baseline and at week 6 of the intervention had a higher body fat percentage
when compared to week 12 and week 18 of the intervention. A LSD post-hoc test
revealed a significant BF percent difference between baseline and week 6 (p = 0.001).
Significance differences among all other phases of the weight loss intervention were
revealed (p < 0.05). There was not a significant interaction between the two treadmill
groups and the intervention phases on BF percent, F (1.34, 14.69) = 0.47, p = 0.560, eta
squared = 0.041, observed power = 0.103. Both groups responded to the weight loss
intervention similarly and body fat percentage decreased similarly between the AlterG
group and the TT group (see Table 4.2).

Physical Activity Levels
The average steps per day for the AlterG group was 7664.71 ± 1983.71 steps,
while the TT group reported an average of 6077.85 ± 2323.46 steps. There was no
significant difference between the two treadmill groups for the average number of steps
walked per day, F (1, 6) = 0.50, p = 0.506, eta squared = 0.077, observed power = 0.092.
There was no significant difference found among the three phases of the intervention, F
(1.14, 6.84) =

1.21, p = 0.319, eta squared = 0.167, observed power = 0.163. Lastly, there was

not a significant interaction between the two treadmill groups, F (1.14, 6.84) = 0.61, p =
0.481, eta squared = 0.093, observed power = 0.106 (see Table 4.3). Daily physical

41
activity patterns remained consistent and were not a factor in the weight loss that
occurred during the walking program.
Table 4.3

Variable
PA Level

Average Step Count Level by Treadmill Group
Week 6

Week 12

Week 18-Post

Total

Mean ±

Mean ±

Mean ±

Mean ±

Group n

SD

SD

SD

SD

AlterG 6

6821.07 ±

8270.20 ±

7189.65 ±

7664.71 ±

1873.62

2440.74

2005.29

1983.71

6889.71 ±

6519.19 ±

5529.45 ±

6077.85 ±

3237.19

2081.47

2339.89

2323.46

(steps/day)
PA Level

TT

(steps/day)

9

* p < 0.05

Numeric Pain Scores
During each exercise session, the participants were asked to rate their level of
lower extremity pain using the 10-point Numeric Pain Scale (NPS). Prior the start of the
weight loss intervention, the average NPS value for all of the participants was 0.50 ±
1.00. There was a statistically significant difference for NPS between the AlterG and TT
groups at baseline, p = 0.048. The TT group had higher NPS scores at the beginning of
the weight loss intervention, 0.94 ± 1.24, compared to the AlterG group, 0.00 ± 0.00. By
the end of the weight loss intervention, the average NPS value for all of the participants
was 0.75 ± 1.23. For the AlterG group, the average NPS value at baseline was 0.00 ±
0.00 and the ending average NPS value was 0.67 ± 1.21. For the TT group, the average
NPS value at baseline was 0.94 ± 1.24 and the post average value was 0.83 ± 1.33.
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Exercise Adherence
There were 18 sessions per each 6-week phase of the study for 54 sessions. Based
on exercise adherence, the AlterG group maintained at least a 79% (43 sessions)
compliance rate over the course of the study, while the TT group demonstrated a 69% (37
sessions) attendance rate (see Table 4.4). No significant differences were found between
the two treadmill groups for total adherence rates (p = 0.25).
Table 4.4

Number of Sessions Completed and Percentages by Treadmill Group
Week 6

Group

n

Sessions

Week 12
n

(%)

Sessions

Week 18n

Post

Total
n

Sessions (%)

Sessions

(%)

(%)
AlterG

6

15 (83%)

6

14 (77%)

6

14 (77%)

6

43 (79%)

TT

9

15 (81%)

9

13 (72%)

7

13 (72%)

9

37 (69%)

Total

15

* p < 0.05

15

13

15

43

CHAPTER FIVE: DISCUSSION AND CONCLUSION

Discussion
The purpose of this study was to determine if the AlterG Anti-Gravity Treadmill
was an effective method for increasing physical activity in a weight loss program when
compared to a traditional treadmill. Four main hypotheses were studied. It was
hypothesized that (1) regular use of the AlterG Anti-Gravity Treadmill would result in
statistically significant exercise-induced weight loss in obese individuals, (2) the
traditional treadmill group (TT) would lose more weight than the AlterG Anti-Gravity
Treadmill (AlterG) group at the conclusion of the intervention, (3) the AlterG group
would have lower Numeric Pain Scores (NPS) while walking than those walking on a
traditional treadmill, and (4) the AlterG group would have higher compliance rates during
the intervention m than the TT group.

Hypothesis 1
The first hypothesis stated that regular use of the AlterG Anti-Gravity Treadmill
would cause statistically significant exercise-induced weight loss. The current study
supported this hypothesis. Weight loss, BMI, and body fat percentage changes on the
AlterG were statistically significant from baseline to the end of the intervention. On
average, those individuals following the AlterG Anti-Gravity walking program lost 2.33
kg over the course of the 18-week program.
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A separate study using a LBPP device in a weight-loss intervention found similar
results to the current study. Participants using the LBPP device produced an overall
weight loss of 4.75 kg (16.1%).33 Although participants in the current study reported
significant weight loss, the amount of loss (2.0%) was less than reported by the previous
study. Similar comparisons between the two studies were also found for total body fat.
The LBPP device group in the above study lost 16.1% total body fat over a period of 12week intervention while participants in the current study only reduced body fat
percentages by 2.0 percent over the course of 18 weeks. This difference could be because
the other study used higher exercise intensities during the intervention. The participants
in that study exercised at 50% V̇O2max for 30 minutes three days per week, whereas
participants in the current study exercise at percentages of maximum heart rates for 30-60
minutes 3 days per week. V̇O2max is the maximum volume of oxygen that the body can
consume during exercise and is more accurate than using estimated maximum heart
rates.1 Using estimated maximum heart rates can under or overestimate the individual’s
true training zone. The current study had low Phase 1 intensity levels, which could have
contributed to the lower overall weight and percent body fat loss at the end of the
intervention.
Weight-loss results of the current study were in disagreement with a previous
study that used the AlterG Anti-Gravity treadmill to determine the effects of a 14-week
walking program with one morbidly obese individual.34 While the participant walked on
the treadmill three times per week, and exercise intensity was kept between 40-60% of
the participant’s heart rate reserve, the researchers found that the walking program was
insufficient to produce significant weight loss.34 The difference between the two studies
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may be explained by the duration and intensity levels of the walking program design.
Participants in the current study increased their intensity levels to 60-85% of maximum
heart rate during the last 6 weeks of the study, whereas the case study maintained an
intensity level of 40-60%. In addition, the current study extended the walking program by
four additional weeks, which could have accounted for the difference in significant
weight loss. While the ASCM recognizes that longer intensity levels at a moderate level
(40 – 60% HRR) may aid in weight loss with obese individuals,1 the extended walking
sessions of the current study may have played a significant role.

Hypothesis 2
It was hypothesized that the traditional treadmill (TT) group would lose more
weight than the AlterG Anti-Gravity Treadmill (AlterG) group; however, results from the
current study did not support this hypothesis. In addition, the results of this study were
not supported by a previous research study that reported that participants using the LBPP
device produced the most amount of weight loss (4.75 kg; 16.1%) when compared to a
traditional treadmill group, a diet only group, and a diet and traditional exercise group.33
The researchers hypothesized that the LBPP group outperformed the other groups due to
the influence of LBPP and the associated increase in blood flow.33
In the current study, both groups lost a significant amount of weight. It was
initially thought that the TT group would lose more weight than the AlterG group
because the traditional treadmill uses full weight-bearing forces while walking, which
could result in additional energy expenditure. Perhaps the weight loss protocol was too
easy for the TT group and the intensity and duration was not enough to demonstrate a
difference in post-intervention weight loss scores. While not significant, the AlterG group
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did demonstrate a higher overall weight loss compared to those walking on the regular
treadmill. Although the reasons for this difference is unclear, those who used the AlterG
could have lost more weight because the participants had to learn to walk in the new
treadmill, requiring them to expend more energy to help maintain balance or increase arm
movements due to walking in the enclosed space.

Hypothesis 3
The third hypothesis was that the AlterG group would have lower Numeric Pain
Scores (NPS) than the TT group. This hypothesis was not supported by the results.
Research has looked at the effects of the AlterG Anti-Gravity Treadmill and other LBPP
devices on reduced GRFs. The LBPP reduces those forces by 49-72%, meaning that
individuals using those devices could preserve gait mechanics, even when limited by
orthopedic issues.31 LBPP has been used in several rehabilitation studies and have been
proven effective in helping post-operative patients reduce their pain and regain muscle
strength due to muscle atrophy caused by initial inactivity.31
The participants who were recruited for this study did not necessarily have
chronic lower extremity pain to begin with. It is also plausible that the walking protocol
for both the AlterG and traditional treadmill was not rigorous enough to create an
inflammatory response and pain in the lower extremities. It is unclear whether increasing
higher intensities earlier in the walking program would have resulted in higher levels of
perceived pain, especially for those walking on the traditional treadmill.
There was one anomaly that occurred during the second phase of the program,
which demonstrated an increase of perceived pain in the AlterG Anti-Gravity Treadmill
group. Three of the participants reported an injury sustained outside of this study. For
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example, one male AlterG group participant competed in a race with his daughter and
twisted his knee while a female TT group participant fell off the sidewalk and broke a rib
and fractured her elbow. Finally, the third injury occurred when another female TT group
participant fell and sustained a third degree ankle sprain, which prevented her from
walking on the treadmill. The two female participants did not participate in Phase three of
the weight loss intervention. This could have affected the NPS results as well because
these two participants did not report their Phase three NPS scores. These independent
injuries could explain why the AlterG group experienced more pain during their walking
sessions in the second phase of the weight loss program.

Hypothesis 4
The fourth hypothesis of this study suggested that the AlterG group would have
higher compliance rates during the intervention than the TT group. While the AlterG
group did attend more exercise sessions (79%) than the TT group (69%), the difference
was not significant. Nevertheless, the six additional days of participation by the AlterG
group may have been due to the uniqueness of the anti-gravity treadmill. Participants in
this group knew that they would be able to walk/jog at faster speeds and greater
elevations with a lower heart rate due to the reduced body weight effect of the special
treadmill. The added anticipation of walking in a special device might have added a
positive psychological component to the exercise sessions, motivating participants to
continue with the walking program. There is evidence to suggest that positive and
negative psychological effects of weight loss can be dependent on a participant’s
perceived success of the n program.21 The AlterG participants in this study may have felt
that they were experiencing positive results or that they were improving their
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cardiovascular level faster due to walking in the device, which could have contributed to
their higher participation rates. As such, it is important to encourage the participant’s
perceived success to help maintain program adherence to the weight loss program. 1,29
One final action may have contributed to the moderate participation rate (73%)
for both groups. Participants in the current study were weighed before every exercise
session. Research has suggested that daily weighing is an important aspect of healthy
dietary and exercise behaviors when associated with weight loss or weight maintenance.36
The action of recording weight in this study may have contributed to exercise adherence
with both groups.
Program adherence is always a concern in weight loss intervention studies.1,22 It is
essential to note that two participants dropped out of the study at the beginning of Phase 3
due to injuries they sustained outside the study. One participant fell off the sidewalk,
broke a rib, and fractured her elbow. The other participant fell and sustained a third
degree ankle sprain, which prevented her from walking on the treadmill. Both of the
participants did return for their final testing at the end of the study. Program adherence
during Phase 3 also became more challenging for others in the study; excuses became
more prevalent. Some of the excuses were “I am too tired,” “I don’t have time to
exercise for 60 minutes,” or “I just don’t feel like it.” Encouragement and positive
motivation by the researcher during Phase 3 helped participants complete the study.

Other Findings
Participants in this study were provided a pedometer to wear during the 18-week
walking program. While no home exercise program was given to the participants, they
were asked to monitor and log total number of steps each day. In addition, participants
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were not informed of recommended step counts or instructed to improve upon daily
counts. Based on pedometer steps, it was found that daily physical activity remained
consistent throughout the duration of the study, with no significant step count differences
occurring within and between groups. In other words, participants in this study
maintained a regular daily routine of physical activity throughout the study. The AlterG
group reported an overall increase of only 844 steps, while participants in the TT group
reduced their daily steps by 812 by the end of the study. No baseline pedometer steps
were taken prior to the start of the study. Despite the lack of baseline step counts, it could
be inferred either that step count values prior to the start of the intervention were similar
or that both treadmill groups responded with daily physical activity to the same degree.
Overall, this outcome demonstrated that daily physical activity was not a factor in the
weight loss results. Therefore, the weight loss gains from this study may be largely
attributed to the 18-week walking program utilizing the AlterG Anti-Gravity Treadmill
and the traditional treadmill.
The step count logs from this study were a bit surprising. Pedometers can be
considered a type of motivation device due to the capability of viewing step counts
throughout the day. Viewing daily steps can motivate individuals to maintain or improve
steps over time.35 In addition, the act of logging and charting step counts at the end of
each day is a form of self-regulation that has been show to enhance motivation and
exercise adherence.35 However, it appeared the participants in this study did not view the
pedometers as anything other than a required task of the study, as opposed to using the
pedometers as a motivational tool to increase daily steps and physical activity levels.
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Limitations
This study consisted of a small sample size of 15 participants. However, other
studies using LBPP devices have also reported a small sample size. One study reported
using used 10 participants over two experimental lab sessions,31 while another study
reported 12 participants in a one-time lab testing. 30
Despite the small number of participants, the results of the current study are
similar to those found in other weight loss studies not using LBPP devices. One study
used a sample size of 40 participants in a six month behavioral weight loss program and
found similar reductions in body weight as compared to this study.28 A second study
analyzed 15,000 participants who self-reported physical activity levels over a 10 year
period and found that increased intensity and frequency resulted in greater amounts of
weight loss, specifically with jogging, aerobics, and cycling.25
This study was also limited in time available for walking sessions each week and
the length of time of the study. There was only one technician available to work with
participants each week. As a result, walking sessions were limited to three days per week
over the course of 18 weeks. A higher frequency of walking sessions per week and a
longer intervention could have possibly shown higher weight loss results. This study was
18 weeks in duration, and most of the research support that long-term weight loss
programs of six months or more are beneficial in producing significant reductions in
weight.
This study did not control for any dietary factors. Dietary logs were not collected
to determine any changes in diet across the study. As such, the weight loss experienced
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by participants in this study may not have been exclusively attributed to effectiveness of
the walking program using the AlterG Anti-Gravity Treadmill and traditional treadmill.
A final limitation of this study was in regards to program adherence. Participants
in this study were not consistent in completing weekly walking sessions during the full
18-week weight loss intervention. The participants had a difficult time adapting to a new
exercise program and exercising three days a week. Most of the participants were not
currently exercising, so this weight loss intervention was a significant lifestyle change for
them. The training days that were missed during the study could have affected the overall
amount of weight loss seen with the participants. If the participants had consistently
attended more sessions, their overall energy expenditure could have resulted in larger
weight losses at the conclusion of the study. In addition, the lack of participation
incentives may have contributed to the inconsistent participation rates.

Future Applications
Although significant weight loss was reported during the 18-week walking
program, the overall loss was less than reported in other studies. Future research should
explore a more aggressive weight loss protocol when using the AlterG Anti-Gravity
Treadmill and traditional treadmill. A more progressive training schedule may produce
larger weight-loss results. Phase 1 of the weight loss protocol was very light in intensity
and would have benefited from a more moderate workload. As such, it is recommended
to use the intensity training level of Phase 2 (40-60% HRR) as part of the initial Phase 1
workload protocol.
It is also recommended to increase the frequency of training sessions to maximize
weight loss potential. The ACSM recommends between 250–300 minutes of physical
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activity each week for obese individuals. Participants in phase one of this study were
completing 90 minutes of walking each week and 135 minutes during phase two. By
phase three, the participants were completing 180 minutes of walking for six weeks. At
no point in this study did the participants complete ACSM’s recommendation of 250-300
minutes of physical activity each week. If the training schedule for the AlterG and
traditional treadmill were to increase by one additional day (e.g., 4 days/week), and
walking sessions were extended, participants would come closer to the recommended
levels of physical activity. Several exercise intervention studies also reported that
extended programs resulted in further reductions in body weight.12,25-27
For future studies, it might beneficial to include completion incentives at the end
of each phase or at the end of the entire program for both treadmill groups in order to
increase exercise adherence rates. Incentives could include water bottles, heart rate
monitors, or even t-shirts to further encourage participants to achieve fitness goals and
recommendations. The use of music or the availability to watch a television program or
movie while walking on the treadmill may also help to enhance the motivational climate
and attendance.
Finally, it is recommended to involve more exercise technicians. Additional help
would allow more participants to be involved in the study, which would increase the
sample size, power of the results, and further validation of the outcomes.

Conclusions
The applicability of this study demonstrated that the walking protocol with the
AlterG Anti-Gravity Treadmill was effective to produce significant decreases in weight
loss, BMI, and percent body fat in obese individuals. In addition, this study supported the
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use of both a traditional treadmill and the AlterG Anti-Gravity Treadmill as effective
exercise tools for increasing physical activity in a weight loss program. This was the first
study to test the effectiveness of the AlterG Anti-Gravity Treadmill against a traditional
treadmill in a weight loss program. Further research is needed to determine the extent of
weight loss potential using the AlterG Anti-Gravity Treadmill with an obese population.
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RESEARCH PARTICIPANTS NEEDED!
The Human Performance Laboratory at Boise State University
needs 40 men and women, aged 18 to 55 years, who would like to
lose weight. If you are overweight or obese, based on the diagram
below left, we want you for an 18-week weight loss study.

Your involvement will be 3 meetings a week for 20 weeks (an 18week training program with pre and post assessment weeks).
Participants will walk on a treadmill 3 times a week and wear a
pedometer (step counter) on the other days. Some participants will
exercise/walk on a standard treadmill and others will use the AlterG
Antigravity Treadmill (above right) that supports a portion of their
body weight.
All of the information gathered will be kept private and confidential.
A free body composition assessment will be provided at the
completion of the study ($60.00 value). In addition, participants will
receive two free subsequent body composition assessments for one
year after study completion* ($120.00 value).
Contact: Kristi Bercier, Graduate Assistant @ (916) 947-5714 or
Kristibercier@u.boisestate.edu
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Health History Questionnaire

Name: __________________

Date: _________________________

Body weight: _____________Height:_____________Birth Date: ________________

1. Gender: Male___ Female____
2. If you are a female, are you pregnant? Yes___ No____
3. General State of Health: Excellent __ Good __ Fair __ Poor __
4. Presently under the care of a physician? No

Yes

5. Month/Year of most recent Physical Exam? ___/___

6. List current medications/drugs (prescription and non-prescription):
(1).______________________ (4).____________________________
None __

(2).______________________ (5).____________________________
(3).______________________ (6).____________________________

7. List Allergies:

Allergy

Reaction

(1).______________________ ________________________________
None __

(2).______________________ ________________________________
(3).______________________ ________________________________

8. Do you have or have ever had: (check all that apply)
__Pain in your heart of chest
__Heart attack
__Heart murmur

__Coughing of blood
__Anemia
__Diabetes
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__Fatigue or lack of energy
__Unusual shortness of breath
__Any heart problem
__Abnormal EKG
__Extra or skipped heart beats
__Elevated cholesterol
__Valve problems
__Diseases of the arteries
__Varicose veins
__Phlebitis
__Dizziness or fainting spells
__Stroke
__High blood pressure
__Badly swollen ankles
__Cough on exertion
__Hemophilia
__Other blood diseases
__Hyperthyroidism

__Epilepsy
__Bronchitis
__Asthma
__Pneumonia
__Emphysema
__Abnormal chest x-ray
__Other lung diseases
__Migraine or recurring headache
__Rheumatic fever
__Nervous or emotional problems
__Injuries to back, arm, legs, joints
__Back pain
__Swollen, stiff, or painful joints
__Arthritis of arms or legs
__Scarlet fever
__Currently pregnant
__Cancer
__ Anorexia nervosa

__Hypothyroidism
__Ulcers

__Bulimia nervosa
__Recent surgery

__Osteoporosis

__Recent head injury/concussions

__Hyperlipidemia

__Fever

__Current infection

__Others

9. Do you have any lower extremity injuries that limit your current mobility?
____Yes _____No
10. Do you have a close blood relative (parent or sibling) who had a heart attack or
sudden death before age 55 (male) or age 65 (female)?
____Yes _____No
12. Do you currently use tobacco? ____Yes _____No
11. Please list anything else you feel we should know about you and your current/past
health:
________________________________________________________________________
____________________________________________________________________
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Boise State University
Department of Kinesiology
Boise State University
1910 University Drive
Boise, Idaho 83725-1710

Weight Loss Training Protocol Using Various Treadmills for Overweight
and Obese Individuals
Informed Consent Form
A. Purpose and Background
I ______________________________________ (please print), agree to participate in a
study entitled “Weight Loss Training Protocol Using the Various Treadmill for Overweight
and Obese Individuals” at the Boise State University to obtain information on the effect
of weight-supported vs. standard treadmills for weight loss. I understand that I will be
randomly selected to participate on either the AlterG Antigravity Treadmill or the
traditional treadmill. In this study, I will complete 2 screening questionnaires, have
physical measures taken; height, weight, body circumference, skinfolds, heart rate, and
blood pressure. The findings of this study may be presented at a conference and/or
published in an academic journal. I am willingly, and without reservation, participating in
the above-titled study, directed by Kristi Bercier, graduate student, and Dr. Shawn
Simonson, faculty, of the Department of Kinesiology.
I am 18 to 55 years old.
B. Procedures
I understand that I will complete the study during the following 55 visits:
Visit 1: Orientation/Informed Consent/Screening (approximately 1 hr)
1. Orientation contacts: The investigators will meet with me at the Human
Performance Laboratory in the Boise State Bronco Gym building and will present
the study’s purpose, the protocols and apparatuses that will be utilized. My
questions concerning the study will also be answered during this meeting.
2. Informed consent: I will read a summary of the study’s procedures and sign this
informed consent form if I agree to participate in the study. I may withdraw from
the study at any time.
3. Screening: I understand that to ensure that I will be physically ready for the
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study’s exercise program, my height, weight, heart rate, and blood pressure will
be measured, and I will complete 2 questionnaires: Health History Questionnaire
and the Numeric Pain Intensity Scale. Based on the information collected, my
eligibility for participation in this study will be determined. It is important that I
answer the questionnaires honestly.
Visits 2-55: Physical Measures of 18 week training program

1. I understand that my metabolic rate will be determined during rest, at a moderate
speed (1.5 – 3.5 mph) and moderately heavy (70% of my estimated maximum)
speed (3.5 – 5.0 mph) at the beginning and at the end of the 18-week weight loss
program. I understand that these measures will help to determine my fitness
levels and response to the protocol. I also understand that if there are any
adverse events during the metabolic testing, that I will be excluded from the
study and it will be recommended that I consult my primary care physician.
2. I will pick a regular 3 days of the week and times that will work for me for the
entire 18-week training program. I understand that the training program will take
place in the Human Performance Lab using the AlterG Antigravity Treadmill or a
traditional treadmill under the supervision of the graduate student and trained
undergraduate interns. I understand that I will be randomly selected to participate
on either the AlterG Antigravity Treadmill or the traditional treadmill.
3. I understand that my heart rate, blood pressure, rating of perceived exertion
(RPE, 0-10 scale measuring how hard I am working) and numeric pain scale
(NPS, 0-10 scale measuring my pain level) scores will be recorded multiple times
per each exercise session.
4. I understand that every 6 weeks (beginning, week 6, week 12, and week 18) I will
come into the Human Performance Lab for body composition testing. I
understand that during these sessions, my blood pressure, heart rate, waist to
hip ratio, calf circumference and Jackson-Pollock 7-site skinfold measurements
will be measured and recorded.
5. I understand that I will be required to keep a written exercise log for the sole
purpose of program adherence and use as a motivational tool. The exercise log
has specific questions for me to answer and I understand that I will turn in this log
at the end of each week. I understand that no data will be collected from this
exercise log. If I decide to keep my exercise log at the completion of the study, I
will be given a copy for my own records.
6. Lastly, I understand that I will be loaned a pedometer to use during the duration
of the 18-week study. I understand that the pedometer will be used to measure
outside physical activity only and will not be worn while I am exercising on the
treadmill, in the shower or sleeping. I understand that the exercise technician will
ask the number of steps I walked for the previous day during each exercise
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session. I will return the pedometer at the end of the study.

C. Risks/Discomforts
Body composition measures: Measuring various body sizes and dimensions
may cause psychological discomfort. Some slight discomfort may be experienced while
using the AlterG Antigravity or traditional treadmills. The researchers are sensitive to
these issues and will strive to optimize the research experience to make me comfortable.
Physical injury: Possible risks for physical activity and exercise include injury
(such as muscular strain), overexertion (leading to fatigue, nausea, headaches,
shortness of breath), and a temporary increase in systolic blood pressure. Researchers
will carefully monitor me during my participation to minimize these risks. In the event I
become sick or injured during the course of the research study, I will immediately notify
my personal physician and the principal investigator.
D. Benefits
Potential benefits expected as a result of my participation have been explained to me,
and include: (a) weight loss, (b) A better understanding of the impact of body fat for
overweight adults (b) a better understanding of appropriate and safe weight loss (c)
better understanding of physical intensity level of physical and daily activities; and (e)
free body composition assessments.
Potential benefits to the larger community include an understanding of the use of a bodyweight supporting treadmill in weight loss and weight management.
E. Confidentiality
Reasonable efforts will be made to keep the personal information in my research record
private and confidential. Any identifiable information obtained in connection with this
study will remain confidential and will be disclosed only with my permission or as
required by law. The information obtained from this study may be used for a statistical or
scientific purpose with my right of privacy upheld. I understand that due to the make-up
of Idaho’s population, the combined answers to some questions in questionnaires
regarding gender, age race and ethnicity, may make an individual person identifiable.
Every effort will be taken by the researchers to protect my confidentiality. However, if I
am uncomfortable answering any of these questions I may leave them blank.
F. Payment/Compensation
I understand that there will be no payment for my participation in this study. In addition to
receiving a free body composition assessment at completion of the study ($60.00 value),
I will receive two free subsequent body composition assessments for one year after
study completion* ($120.00 value; *Non-transferrable and limited to every other month).
G. Questions/Voluntary Participation/Withdrawal
I may withdraw from this study at any time without penalty. The decision to participate,
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decline, or withdraw participation will have no effect on my relationship with Boise State
University. I have been given an opportunity to ask questions concerning the information
given to me. I understand that I may contact Dr. Shawn Simonson at (208) 426-3973 or
ShawnSimonson@boisestate.edu, or the Boise State Institutional Review Board at (208)
426-5401 between 8:00 AM and 5:00 PM, Monday through Friday or Institutional Review
Board, Office of Research Compliance, Boise State University, 1910 University Dr.,
Boise, ID 83725-1138.
H. Consent
I have read, or have had read to me, all of the above information about this research
study, including the research procedure, possible risks, and the likelihood of any benefits
to me. My questions have been satisfactorily answered. I hereby consent and voluntarily
offer to follow the study requirements and take part in the study.
I will receive a signed copy of this form.

Participant

Printed Name

Date

Researcher

Printed Name

Date
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